Serkan Atıcı
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 17
- Pneumonia and Respiratory Infections 5
- Cytomegalovirus and herpesvirus research 4
-
- SARS-CoV-2 and COVID-19 Research 4
- Clostridium difficile and Clostridium perfringens research 3
- Co-authors
- Ahmet Soysal (35 shared papers)Mustafa Bakır (25 shared papers)Ayşe Karaaslan (20 shared papers)Eda Kepenekli (18 shared papers)Gülşen Akkoç (16 shared papers)Nurhayat Yakut (16 shared papers)Sevliya Öcal Demi̇r (15 shared papers)Güner Söyletir (7 shared papers)
- Journals
- SpringerPlus (3 papers)Human Vaccines & Immunotherapeutics (2 papers)Vaccine (1 paper)Global Pediatric Health (1 paper)PLoS ONE (1 paper)
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
Serkan Atıcı
35 papers receiving 415 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 54
- Applied Microbiology and Biotechnology 16
- Infectious Diseases 137
- Microbiology 35
- Endocrinology 26
Countries citing papers authored by Serkan Atıcı
This map shows the geographic impact of Serkan Atıcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serkan Atıcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serkan Atıcı more than expected).
Fields of papers citing papers by Serkan Atıcı
This network shows the impact of papers produced by Serkan Atıcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serkan Atıcı. The network helps show where Serkan Atıcı may publish in the future.
Co-authors
The 25 scholars most cited alongside Serkan Atıcı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 58 | |
| 2 | 2017 | 42 | |
| 3 | 2021 | 27 | |
| 4 | 2020 | 26 | |
| 5 | 2016 | 25 | |
| 6 | 2016 | 25 | |
| 7 | 2016 | 19 | |
| 8 | 2016 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 2016 | 14 | |
| 11 | 2016 | 14 | |
| 12 | 2016 | 14 | |
| 13 | 2015 | 13 | |
| 14 | 2014 | 11 | |
| 15 | 2014 | 9 | |
| 16 | 2016 | 9 | |
| 17 | 2015 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2017 | 8 | |
| 20 | 2018 | 7 |
About Serkan Atıcı
Serkan Atıcı is a scholar working on Epidemiology, Infectious Diseases, Surgery, Ophthalmology and Endocrinology, having authored 39 papers that have together received 431 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Bacterial Infections and Vaccines (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Infections and bacterial resistance (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Kawasaki Disease and Coronary Complications (3 papers). The work is most often cited by research in Molecular Medicine (54 citations), Applied Microbiology and Biotechnology (16 citations), Infectious Diseases (137 citations), Microbiology (35 citations) and Endocrinology (26 citations). Serkan Atıcı has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Ahmet Soysal, Mustafa Bakır, Ayşe Karaaslan, Eda Kepenekli, Gülşen Akkoç, Nurhayat Yakut, Sevliya Öcal Demi̇r, Güner Söyletir, Uluhan Sili and Gürsu Kıyan. Their work appears in journals such as SpringerPlus, Human Vaccines & Immunotherapeutics, Vaccine, Global Pediatric Health and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.